Skip to menu Skip to content Skip to footer

1998

Journal Article

The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK

Rees, E, Hardy, J, Ling, J, Broadley, K and A'Hern, R (1998). The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliative Medicine, 12 (2), 75-82. doi: 10.1191/026921698674135173

The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK

1997

Journal Article

Placebo-controlled trials in palliative care: the argument for

Hardy, JR (1997). Placebo-controlled trials in palliative care: the argument for. Palliative Medicine, 11 (5), 415-418. doi: 10.1177/026921639701100514

Placebo-controlled trials in palliative care: the argument for

1997

Journal Article

Palliative medicine in cancer

Stone, Patrick and Hardy, Janet (1997). Palliative medicine in cancer. The Lancet, 350 (9073), 296. doi: 10.1016/s0140-6736(05)62270-2

Palliative medicine in cancer

1997

Journal Article

Can transdermal fentanyl cause diarrhea?

Hardy, Janet R. (1997). Can transdermal fentanyl cause diarrhea?. Journal of Pain and Symptom Management, 13 (4), 188-189. doi: 10.1016/s0885-3924(97)00037-7

Can transdermal fentanyl cause diarrhea?

1995

Journal Article

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD)

Ling, P. J., Ahern, R. P. and Hardy, J. R. (1995). Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD). British Journal of Cancer, 72 (1), 206-209. doi: 10.1038/bjc.1995.304

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD)

1995

Journal Article

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

Ellis, P. A., Smith, I. E., Hardy, J. R., Nicolson, M. C., Talbot, D. C., Ashley, S. E. and Priest, K. (1995). Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. British Journal of Cancer, 71 (2), 366-370. doi: 10.1038/bjc.1995.74

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

1995

Journal Article

Subcutaneous Ketorolac

Duncan, AR, Hardy, JR and Davis, CL (1995). Subcutaneous Ketorolac. Palliative Medicine, 9 (1), 77-78. doi: 10.1177/026921639500900111

Subcutaneous Ketorolac

1994

Journal Article

Current issues in cancer palliative care

Davis, C. L. and Hardy, J. R. (1994). Current issues in cancer palliative care. BMJ, 308 (6940), 1359-1362. doi: 10.1136/bmj.308.6940.1359

Current issues in cancer palliative care

1994

Journal Article

Prediction of Survival in a Hospital-Based Continuing Care Unit

Hardy, JR, Turner, R, Saunders, M and Ahern, R (1994). Prediction of Survival in a Hospital-Based Continuing Care Unit. European Journal of Cancer, 30A (3), 284-288. doi: 10.1016/0959-8049(94)90242-9

Prediction of Survival in a Hospital-Based Continuing Care Unit

1994

Journal Article

An audit of morphine prescribing in a specialist cancer hospital

Turner, Rose, Clark, Judith, Root, Timothy and Hardy, Janet (1994). An audit of morphine prescribing in a specialist cancer hospital. Palliative Medicine, 8 (1), 5-10. doi: 10.1177/026921639400800102

An audit of morphine prescribing in a specialist cancer hospital

1992

Journal Article

A Phase-Ii Study of Sulofenur, a Novel Sulfonylurea, in Recurrent Epithelial Ovarian-Cancer

Obrien, Mer, Hardy, J, Tan, S, Walling, J, Peters, B, Hatty, S and Wiltshaw, E (1992). A Phase-Ii Study of Sulofenur, a Novel Sulfonylurea, in Recurrent Epithelial Ovarian-Cancer. Cancer Chemotherapy and Pharmacology, 30 (3), 245-248. doi: 10.1007/BF00686324

A Phase-Ii Study of Sulofenur, a Novel Sulfonylurea, in Recurrent Epithelial Ovarian-Cancer

1991

Journal Article

Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer

Harvey, VJ, Hardy, JR, Smith, S, Grove, W and Baguley, BC (1991). Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer. European Journal of Cancer, 27 (12), 1617-1620. doi: 10.1016/0277-5379(91)90427-F

Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer

1991

Journal Article

Hypoprothrombinemia From Coadministration of Sulofenur (ly-186641) and Warfarin - Report of 3 Cases

Fossella, FV, Lippman, SM, Seitz, DE, Alberts, DS, Taylor, CW, Wiltshaw, E, Hardy, J, Obrien, M, Haynes, TR and Wolen, RL (1991). Hypoprothrombinemia From Coadministration of Sulofenur (ly-186641) and Warfarin - Report of 3 Cases. Investigational New Drugs, 9 (4), 357-359.

Hypoprothrombinemia From Coadministration of Sulofenur (ly-186641) and Warfarin - Report of 3 Cases

1991

Journal Article

Lymphedema - Prevention Rather Than Cure

Hardy, JR (1991). Lymphedema - Prevention Rather Than Cure. Annals of Oncology, 2 (8), 532-533. doi: 10.1093/oxfordjournals.annonc.a058015

Lymphedema - Prevention Rather Than Cure

1991

Journal Article

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer

Powles, T. J., Jones, A. L., Judson, I. R., Hardy, J. R. and Ashley, S. E. (1991). A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer. British Journal of Cancer, 64 (2), 406-410. doi: 10.1038/bjc.1991.318

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer

1991

Journal Article

The Pharmacokinetics of Oral Lonidamine in Breast and Lung-Cancer Patients

Newell, DR, Mansi, J, Hardy, J, Button, D, Jenns, K, Smith, IE, Picollo, R and Catanese, B (1991). The Pharmacokinetics of Oral Lonidamine in Breast and Lung-Cancer Patients. Seminars in Oncology, 18 (2), 11-17.

The Pharmacokinetics of Oral Lonidamine in Breast and Lung-Cancer Patients

1991

Journal Article

Cisplatin and Carboplatin in Combination for the Treatment of Stage-Iv Ovarian-Carcinoma

Hardy, JR, Wiltshaw, E, Blake, PR, Harper, P, Slevin, M, Perren, TJ and Tan, S (1991). Cisplatin and Carboplatin in Combination for the Treatment of Stage-Iv Ovarian-Carcinoma. Annals of Oncology, 2 (2), 131-136. doi: 10.1093/oxfordjournals.annonc.a057876

Cisplatin and Carboplatin in Combination for the Treatment of Stage-Iv Ovarian-Carcinoma

1991

Journal Article

Clinical-Study and Pharmacokinetics of Lonidamine in Advanced Non-Small Cell Lung-Cancer

Jones, AL, Hardy, JR, Newell, DR and Smith, IE (1991). Clinical-Study and Pharmacokinetics of Lonidamine in Advanced Non-Small Cell Lung-Cancer. European Journal of Cancer, 27 (4), 519-519. doi: 10.1016/0277-5379(91)90403-Z

Clinical-Study and Pharmacokinetics of Lonidamine in Advanced Non-Small Cell Lung-Cancer

1990

Conference Publication

NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER

HARDY, J, TAN, S, FRYATT, and WILTSHAW, E (1990). NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER. BASINGSTOKE: STOCKTON PRESS.

NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER

1990

Journal Article

Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer

Jones, A. L., Williams, M. P., Powles, T. J., Oliff, J. F. C., Hardy, J. R., Cherryman, G. and Husband, J. (1990). Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer. British Journal of Cancer, 62 (2), 296-298. doi: 10.1038/bjc.1990.281

Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer